A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
Tekijät: Reyes Saúl, Cunningham Anthony L., Kalincik Tomas, Havrdová Eva Kubala, Isobe Noriko, Pakpoor Julia, Airas Laura, Bunyan Reem F., van der Walt Anneke, Oh Jiwon, Mathews Joela, Mateen Farrah J., Giovannoni Gavin
Kustantaja: Elsevier B.V.
Julkaisuvuosi: 2021
Journal: Journal of Neuroimmunology
Tietokannassa oleva lehden nimi: Journal of Neuroimmunology
Artikkelin numero: 577627
Vuosikerta: 357
eISSN: 1872-8421
DOI: https://doi.org/10.1016/j.jneuroim.2021.577627
Rinnakkaistallenteen osoite: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/
In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues.